PER-SAF_PDOS (Performance and Safety of Polydioxanone Suture)

Evaluation of the Performance and Safety of Polydioxanone Suture (PDO) "Bio Meyisun" for the Temporary Correction of the Mid-face Area.

This clinical investigation aims to confirm the safety and efficacy of the ID in facial soft tissue reconstruction, specifically for non-incision surgery to tighten and lift the facial skin for a rejuvenated facial appearance.

Inclusion Criteria:

• Patients over 18 years old with full legal capacity, male and female;
• Patients with ability to understand the proposed aesthetic correction and to understand and sign informed consent;
• Patients who are willing and able to comply with scheduled visits, aesthetic correction procedure and other trial procedures.

Exclusion Criteria:

• Pregnant or breast--feeding women;
• Patients currently participating in any other clinical investigation;
• Patients who have received a vaccine within 14 days prior to the baseline or plan to have vaccine within 14 days after the injection;
• Patients with a medical history of systemic diseases, including severe kidney, liver, heart and neurological disorders.